RFK Jr's US Vaccine Policy Sparks Global Debate Around Gavi Ultimatum and Birth-Dose Hepatitis B Trial

Summary

In this episode, NPR examines how Robert F. Kennedy Jr."s vaccine priorities, voiced through his team and the administration, are affecting global health policy. Two high-profile case studies illustrate the widening international impact: first, RFK Jr."s push to withhold U.S. funding from Gavi unless the vaccine alliance removes thimerosal from its multi-dose vaccines; second, a controversial hepatitis B study in Guinea-Bissau funded in part by the United States, testing birth-dose vaccination against later vaccination in a setting with limited resources. The discussion features voices from public health experts who question the ethics and feasibility of these moves and explore the potential consequences for global immunization programs.

Introduction: US vaccine priorities and global reverberations

The episode opens by framing RFK Jr."s role and his long-standing skepticism about thimerosal, a mercury-containing preservative used in some vaccines. The host explains that two concrete, globally relevant episodes have emerged from the new US vaccine posture: (1) the ultimatum to Gavi, the international vaccine alliance, and (2) a proposed hepatitis B birth-dose study in Guinea-Bissau, funded in part by the United States. As the conversation unfolds, NPR distinguishes between policy debates inside the United States and the international responses they provoke, highlighting how public health norms and funding flows are being tested on the world stage.

"I think I've noticed over the past year that the US is getting more isolated when it comes to public health, being called out publicly as supporting things that are unethical or go against science." - Gabriela Emmanuel, NPR Global Health Correspondent